| 标题 |
A phase I study of DNIB0600A, an antibody-drug conjugate (ADC) targeting NaPi2b, in patients (pts) with non-small cell lung cancer (NSCLC) or platinum-resistant ovarian cancer (OC) |
| 网址 | |
| DOI | |
| 其它 |
期刊:Journal of Clinical Oncology 作者:Howard A. Burris; Michael S. Gordon; David E. Gerber; David R. Spigel; David S. Mendelson; et al 出版日期:2014 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)